Table 5 Three-year survival in the 346 patients with N+ disease treated with vs. without concurrent chemotherapy
No concurrent chemotherapy | With concurrent chemotherapy | P Value | |
|---|---|---|---|
MFS | 82.5 | 83.7 | 0.50 |
DFS | 79.3 | 81.7 | 0.66 |
OS | 88.3 | 88.5 | 0.85 |
No concurrent chemotherapy | With concurrent chemotherapy | P Value | |
|---|---|---|---|
MFS | 82.5 | 83.7 | 0.50 |
DFS | 79.3 | 81.7 | 0.66 |
OS | 88.3 | 88.5 | 0.85 |